Novonesis A/S (NVZMF) Q1 2025 Earnings Call Transcript

2025-05-11 10:32:06 ET

Novonesis A/S (NVZMF)

Q1 2025 Earnings Conference Call

May 08, 2025, 03:00 AM ET

Company Participants

Tobias Björklund - Head, Investor Relations

Ester Baiget - Chief Executive Officer

Rainer Lehmann - Chief Financial Officer

Amy Byrick - Executive Vice President, Human Health Biosolutions

Tina Fano - Executive Vice President, Planetary Health Biosolutions

Claus Crone Fuglsang - Chief Scientific Officer

Conference Call Participants

Alex Sloane - Barclays

Matthew Yates - Bank of America

Thomas Lind Petersen - Nordea

Charles Eden - UBS

Ranulf Orr - Citibank

Søren Samsøe - SEB

Nicola Tang - BNP Paribas

Chetan Udeshi - JP. Morgan

André Thormann - Danske Bank

Presentation

Operator

Tobias Björklund

Thank you very much, operator, and welcome, everyone, to the Novonesis Conference Call for the First Quarter of 2025. My name is Tobias Björklund, and as said, I'm heading up our Investor Relation activities here at Novonesis.

In this call, our CEO, Ester Baiget, and our CFO, Rainer Lehmann, will review our performance for the year, as well as the outlook for 2025. Also that are attending today's calls are Amy Byrick, EVP of Human Health Biosolutions, Tina Fano, EVP of Planetary Health Biosolutions, and Claus Fuglsang, Chief Scientific Officer. The conference call will take about 45 minutes, including Q&A. Please change to the next slide....

Read the full article on Seeking Alpha

For further details see: